
T2 Biosystems TTOO
Land |
|
IPO-Jahr |
2014 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
2.61 M |
Marktkapitalisierung |
$ 313 K |
EBITDA (LTM) |
$ -44.8 M |
P/E (LTM) |
- |
P/S (LTM) |
0.04 |
EPS (LTM) |
-7.32 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Celcuity
CELC
|
$ 91.89 | -0.96 % | $ 4.3 B | Nasdaq Global Select Market | ||
|
DarioHealth Corp.
DRIO
|
$ 7.11 | -8.08 % | $ 28.3 M | Nasdaq Capital Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Interpace Biosciences
IDXG
|
$ 1.65 | 2.48 % | $ 7.3 M | Nasdaq Global Select Market | ||
|
ICON Public Limited Company
ICLR
|
$ 165.05 | 0.33 % | $ 12.9 B | Nasdaq Global Select Market,SPB | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
IQVIA Holdings
IQV
|
$ 241.79 | 1.29 % | $ 41.6 B | NYSE,SPB | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | ||
|
NeoGenomics
NEO
|
$ 16.62 | 0.3 % | $ 2.13 B | Nasdaq Global Select Market,SPB | ||
|
Co-Diagnostics
CODX
|
$ 1.51 | -0.66 % | $ 2.01 M | Nasdaq Capital Market | ||
|
Charles River Laboratories International
CRL
|
$ 269.25 | 0.66 % | $ 13.3 B | NYSE,SPB | ||
|
ENDRA Life Sciences
NDRA
|
$ 4.47 | -2.83 % | $ 3.52 M | Nasdaq Global Select Market | ||
|
National Research Corporation
NRC
|
$ 20.38 | 0.2 % | $ 456 M | Nasdaq Global Select Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Myriad Genetics
MYGN
|
$ 3.32 | 1.84 % | $ 307 M | Nasdaq Global Select Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 237.17 | -0.5 % | $ 26.3 B | NYSE,SPB | ||
|
Biomerica
BMRA
|
$ 1.6 | -0.62 % | $ 3.68 M | Nasdaq Capital Market | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | ||
|
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | ||
|
Anixa Biosciences
ANIX
|
$ 3.32 | -2.92 % | $ 108 K | Nasdaq Capital Market | ||
|
Precipio
PRPO
|
$ 23.62 | -1.48 % | $ 37.9 M | Nasdaq Global Select Market | ||
|
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | ||
|
Quidel Corporation
QDEL
|
$ 12.87 | 4.76 % | $ 542 M | Nasdaq Global Select Market,SPB | ||
|
Natera
NTRA
|
$ 318.83 | -1.02 % | $ 43.6 B | Nasdaq Global Select Market,SPB | ||
|
DexCom
DXCM
|
$ 87.52 | 3.26 % | $ 34.2 B | Nasdaq Global Select Market,SPB | ||
|
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | ||
|
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | ||
|
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market | ||
|
Senseonics Holdings
SENS
|
$ 7.61 | 8.41 % | $ 318 M | NYSE American | ||
|
Sotera Health Company
SHC
|
$ 18.73 | -0.69 % | $ 5.32 B | Nasdaq Global Select Market | ||
|
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB |